TVGN
Tevogen Inc. - Common Stock (TVGN)
$81
About Tevogen Inc. - Common Stock (TVGN)
Tevogen, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. It focuses on its product, ExacTcell, a technology that treats acute viral infections, long-term consequences of viral infections, and viral and non-viral induced cancers. The company was founded in April 2021 and is headquartered in Warren, NJ.
Details
Daily high
$7.81
Daily low
$7.43
Price at open
--
52 Week High
$43.66
52 Week Low
$3.64
Market cap
50.9M
Dividend yield
-
Volume
1
Avg. volume
8,514
P/E ratio
-1.34
Tevogen Inc. - Common Stock News
Details
Daily high
$7.81
Daily low
$7.43
Price at open
--
52 Week High
$43.66
52 Week Low
$3.64
Market cap
50.9M
Dividend yield
-
Volume
1
Avg. volume
8,514
P/E ratio
-1.34